Eckert & Ziegler: Major Order for Prostate Implants

Berlin, (PresseBox) - The Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a firm specializing in medical use of radioactivity, has gained over its Belgian subsidiary IBt BEBIG (International Brachytherapy S.A.) a major order in France for the supply of medical devices for prostate cancer treatment.

During the next three years the specialist in radiation therapy will deliver miniature implants, typically used to treat early stage prostate cancer, to specialised hospitals in Angers, Caen, Nice, Strasbourg and Rouen. The multiple million Euro contract contains also the supply of the renowned Institut Curie in Paris, where brachytherapy was born. Presumably more than 1,000 patients will benefit from the low-level radioactive implants.

The commissioning hospitals are part of Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC), a consortium of 20 well-known French cancer research centers, in which the state activities in the area of cancer treatment and research are coordinated.

Eckert & Ziegler Strahlen- und Medizintechnik AG

The Eckert & Ziegler Group, with around 520 employees, is one of the world's largest providers of isotope technology components for radiotherapy and nuclear medicine.

Press releases you might also be interested in

Weitere Informationen zum Thema "Medizintechnik":

Was erwartet die datengetriebene Wirtschaft 2018?

Künst­li­che In­tel­li­genz (KI) war ver­gan­ge­nes Jahr ei­nes der Trend­the­men. Und auch in den Ex­per­ten­prog­no­sen für 2018 ist sie ein fes­ter Be­stand­teil. Die Fra­ge ist al­so we­ni­ger, ob, son­dern wie KI und da­mit ver­bun­de­ne Tech­no­lo­gi­en wie Ma­chi­ne Lear­ning in den nächs­ten Mo­na­ten die Un­ter­neh­mens­welt ve­r­än­dern wer­den.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.